The Sodium Channel Protein Type 11 Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Sodium Channel Protein Type 11 Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Sodium Channel Protein Type 11 Subunit Alpha pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, Toxicology, and Genetic Disorders which include the indications Post-Operative Pain, Pain, Chemotherapy Induced Peripheral Neuropathy, and Erythromelalgia. It also reviews key players involved in Sodium Channel Protein Type 11 Subunit Alpha targeted therapeutics development with respective active and dormant or discontinued products.
The Sodium Channel Protein Type 11 Subunit Alpha pipeline targets constitutes close to ten molecules. Out of which, approximately nine molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, and Preclinical stages are 1, 1, 3, and 4 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Sodium Channel Protein Type 11 Subunit Alpha overview
Sodium channel protein type 11 subunit alpha (SCN11A) is a sodium channel mediating the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. SCN11A is involved in membrane depolarization during action potential in nociceptors which function as key relay stations for the electrical transmission of pain signals from the periphery to the central nervous system.
For a complete picture of Sodium Channel Protein Type 11 Subunit Alpha’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.